Aldesleukin Completed Phase 1 Trials for Childhood Solid Neoplasm / Adult Solid Neoplasm / Neoplasms, Metastatic Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02775292Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1